Advanced wound dressings are essential medical tools used to protect wounds, cuts, and burns from infections while aiding the wound healing process through the controlled release of beneficial biomaterials. However, some wounds face challenges, experiencing prolonged inflammation leading to chronicity. This study addresses this issue by introducing a ground-breaking approach in wound dressing technology, focusing on the fabrication of gelatin nanofiber scaffolds integrated with therapeutic Spirulina algae extracts. Here, water-based spirulina algae extract is loaded into the gelatin nanofibers during electrospinning process. Final nanofibrous structure is cross-linked by glutaraldehyde vapor. Results show that the average diameter of nanofibers containing spirulina is $144 \pm 41$ nm and this diameter is increased after cross-linking. In addition, through optimized cross-linking of gelatin nanofibers via glutaraldehyde within 90 minutes, based on results of test the dressing maintains their structural integrity for at least one weeks. This innovative combination offers a promising avenue to potential overcome challenges associated with prolonged inflammation, presenting a novel and effective solution for acute wound treatment and optimal tissue regeneration. The reason that UV device did not recognize the spirulina released could be because of the UV device precision, also another reason could be because of deterioration of proteins inside of Spirulina during crosslinking. Also, for this project only preliminary experiments were done so with more advanced experiments we could see more results.